Right breast cancer with contralateral axillary lymph-node metastasis

This breast cancer diagnosis at a glance

Stage at diagnosis
Stage IV
Subtype
Invasive Ductal Carcinoma
Biomarkers
Right breast primary: ER-positive; PR-positive; HER2-negative; Ki-67 70%. Left axillary metastasis: ER-positive; PR-negative; HER2-negative; Ki-67 15%; GATA3-positive.
Sex
Female
Spread to
contralateral left axillary lymph nodes
Treatment
surgery and surveillance
Outcome
Cancer-Free / NED

Treatment course, step by step

  1. Bilateral modified radical mastectomy with bilateral axillary lymph-node dissection was performed.
  2. She was referred to oncology for adjuvant chemotherapy.
  3. Six-monthly clinical and radiological surveillance continued.

What happened, in summary

A 61-year-old woman sought care for a right breast lump that she had noticed for three months. Examination found a hard mass in the right lower outer breast and enlarged lymph nodes in both axillae, although no left-breast mass was palpable. Imaging and tissue assessment did not identify a separate primary cancer in the left breast or disease outside the breast and axillary regions.

She underwent bilateral modified radical mastectomy with bilateral axillary dissection. The right breast contained a 2 to 3 cm grade 1 invasive ductal carcinoma. One of 26 right axillary nodes and three intramammary nodes contained cancer. All 16 removed left axillary nodes also contained metastatic carcinoma, while the left breast showed only fibrocystic changes. The right primary was ER-positive, PR-positive, HER2-negative, and had a Ki-67 index of 70%. The left axillary metastasis was ER-positive, PR-negative, HER2-negative, GATA3-positive, and had a Ki-67 index of 15%.

Her synchronous contralateral axillary spread was classified as stage IV disease. She recovered without postoperative complications and was referred to oncology for adjuvant chemotherapy. She continued clinical and radiological follow-up every six months. Two years after surgery, there was no evidence of metastasis or recurrence.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar breast cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more breast cancer stories